Tenet Healthcare diskutieren
Tenet Healthcare
WKN: A1J5US / Symbol: THC / Name: Tenet Healthcare / Aktie / Anbieter & Dienstleistungen / Mid Cap /
169,00 €
-0,59 %
Tenet Healthcare Corporation (NYSE: THC) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $200.00 price target on the stock, up previously from $185.00.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Corporation (NYSE: THC) had its price target raised by analysts at UBS Group AG from $230.00 to $238.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Corporation (NYSE: THC) had its price target lowered by analysts at Barclays PLC from $215.00 to $208.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Corporation (NYSE: THC) had its price target raised by analysts at JPMorgan Chase & Co. from $190.00 to $200.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare Corporation (NYSE: THC) had its price target raised by analysts at Wells Fargo & Company from $195.00 to $200.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $190.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target raised by analysts at Bank of America Corporation from $205.00 to $225.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target raised by analysts at Barclays PLC from $208.00 to $229.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $190.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) was given a new $238.00 price target on by analysts at Wells Fargo & Company. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its "overweight" rating reaffirmed by analysts at KeyCorp. They now have a $225.00 price target on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target raised by analysts at Cantor Fitzgerald from $190.00 to $245.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) was given a new $232.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target raised by analysts at Royal Bank Of Canada from $230.00 to $252.00. They now have an "outperform" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $240.00 price target on the stock, up previously from $225.00.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target raised by analysts at Wells Fargo & Company from $238.00 to $252.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target raised by analysts at JPMorgan Chase & Co. from $200.00 to $230.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) had its price target raised by analysts at Guggenheim from $238.00 to $257.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat
Tenet Healthcare (NYSE:THC) was downgraded by analysts at Wall Street Zen from a "strong-buy" rating to a "buy" rating.
Ratings data for THC provided by MarketBeat
Neueste Beiträge
TD_Cowen in Servicenow Inc. diskutieren, ServiceNow Inc.